Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Crackdown on Pharma Influence: Govt Bans Medical Reps from Central Hospitals

Farhat Nasim3 Jun 2025 6:28 PM IST

New Delhi: The Directorate General of Health Services (DGHS) under the Ministry of Health and Family Welfare has directed all central government...

Over Rs 2 Cr Semaglutide Theft at Dr Reddys Srikakulam Unit, Staff Among 8 Arrested

Dr Reddy's Gets Rs 2,395 Crore Tax Notice Over Merger, Says No Material Impact

Farhat Nasim2 Jun 2025 12:27 PM IST

New Delhi: Drug major, Dr. Reddy's Laboratories Ltd. has disclosed that it has received an order from the Income Tax Department under Section 148A(3)...

ASCI Flags 233 Health Ads for DMR Act Violation, Reports to AYUSH Ministry

Farhat Nasim1 Jun 2025 3:00 PM IST

New Delhi: In a robust effort to regulate misleading health-related advertisements, the Advertising Standards Council of India (ASCI) has flagged 233...

Don't throw in the bin, please flush it! CDSCO dictum for these 17 medicines

Farhat Nasim31 May 2025 6:21 PM IST

New Delhi: In a move to streamline the disposal of expired or unused medicines, the Central Drugs Standard Control Organisation (CDSCO) has issued a...

Centre Lists 34 Antimicrobials, Antivirals for Proposed Ban in Animals Under Drugs Act

Farhat Nasim27 May 2025 7:39 PM IST

New Delhi: The Central Government has issued a draft notification proposing the prohibition of import, manufacture, sale, and distribution of a total...

PCI Orders Pharmacy Colleges to Submit UGC Anti-Ragging Compliance Report by June 1

Farhat Nasim27 May 2025 7:38 PM IST

New Delhi: The Pharmacy Council of India (PCI) has issued a directive to all pharmacy institutions under its purview to strengthen their compliance...

Delhi HC Closes Plea by Doctor Challenging Closing of Facebook Account for Allegedly Glorifying Dangerous Organisations

Delhi HC Quashes IPO's Patent Rejection of Taiho Pharma's Cancer Drug, Orders Re-evaluation

Farhat Nasim25 May 2025 4:00 PM IST

New Delhi: In a ruling impacting pharmaceutical patent jurisprudence in India, the Delhi High Court has set aside the Indian Patent Office's (IPO)...

Macleods Gets CDSCO Panel Go Ahead For Semaglutide Trials, Preclinical Data Sought

Farhat Nasim24 May 2025 9:54 PM IST

New Delhi: The Subject Expert Committee (SEC) on Endocrinology and Metabolism, operating under the Central Drugs Standard Control Organisation...

Substandard Drugs Flagged Across Multiple States, Over 130 Batches Fail Quality Tests In April

Farhat Nasim22 May 2025 6:45 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has flagged 136 batches of pharmaceutical products as Not of Standard Quality (NSQ)...

Zydus' Desidustat Gets Expert Panel Nod for Phase-III Trial in Cancer-Related Anemia

Farhat Nasim21 May 2025 8:05 PM IST

New Delhi: The Subject Expert Committee (SEC) on Haematology has recommended for grant of permission to conduct a Phase-III clinical trial for...

CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III Trial

CDSCO Panel Recommends Protocol Amendment for Novartis' Ianalumab Trial

Farhat Nasim21 May 2025 8:03 PM IST

New Delhi: The Subject Expert Committee (SEC) on Haematology, functional under the Central Drugs Standard Control Organisation (CDSCO) has recommended...

USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz

Farhat Nasim20 May 2025 8:24 PM IST

US: In a stern regulatory move, the United States Food and Drug Administration (USFDA) has issued a warning letter to Virginia-based Sarfez...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok